2030, Compounding and Pharmaceutical Manufacturing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2030

Compounding

Pharmaceutical Manufacturing

As Trump Pharma Tariff Deadline Looms, Here's How the Sector Got Here

Pharmaceutical Commerce

JULY 31, 2025

We have evidence of foreign manufacturers cutting corners and having less than high-quality standards.” 26 – Eli Lilly and Company announces that it will be constructing four new pharmaceutical manufacturing sites in the United States, representing financial commitments in the expansion space exceeding $50 billion since the start of 2020.

Insurance Coverage and Processing

Insurance Coverage and Processing Drug Pricing Packaging Sterile Compounds

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. So, when could the goal of a net zero pharmaceutical industry be achieved?

Compounding

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies

Pharmacist Digest

As Trump Pharma Tariff Deadline Looms, Here's How the Sector Got Here

Building CO2-neutral, defossilised supply chains for chemicals

Stay Connected